# Icariin to Prevent Corticosteroid-related Memory Changes

> **NCT02112123** · PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 24 (actual)

## Conditions studied

- the Pharmacokinetic Profile of Icariin in Humans

## Interventions

- **DRUG:** Icariin
- **DIETARY_SUPPLEMENT:** Matching placebo

## Key facts

- **NCT ID:** NCT02112123
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-09
- **Final completion:** 2016-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02112123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02112123, "Icariin to Prevent Corticosteroid-related Memory Changes". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02112123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*